ERYTECH PHARMA's ticker is ERYP and the CUSIP is 29604W108. A total of 8 filers reported holding ERYTECH PHARMA in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 625,000 | $13,763,000 | 1.66% |
| Baker Brothers Advisors | 3,090,069 | $68,043,000 | 0.59% |
| NEA Management Company, LLC | 625,000 | $13,763,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 120,000 | $2,642,000 | 0.31% |
| Delek Group, Ltd. | 70,000 | $1,539,000 | 0.08% |
| JANE STREET GROUP, LLC | 27,344 | $607,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 43,567 | $959,000 | 0.00% |
| UBS Group AG | 1,637 | $36,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 570 | $13,000 | 0.00% |
| MACQUARIE GROUP LTD | 600 | $13,000 | 0.00% |